This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Huron Consulting Group Launches Clinical Trial Data Analytics And Visualization Service

Huron Consulting Group (NASDAQ: HURN), a leading provider of business consulting services, today announced the launch of its trialRxtm service, a Huron Life Sciences clinical trial data monitoring service that helps pharmaceutical, biotechnology and medical device companies understand and mitigate clinical trial disclosure risks.

Huron Life Sciences’ trialRx service is enabled by a unique, proprietary data analytics and visualization tool that leverages a database of the 32 million unique data points available on the National Institutes of Health’s (NIH) website, The trialRx service provides an accurate, automated way to monitor clinical trial registration and results reporting compliance, allowing companies to develop focused strategies to mitigate clinical trial disclosure risks efficiently.

“The trialRx service provides life sciences companies with a straightforward, efficient way to monitor all publicly available information posted on Based on this information, they can generate insights to inform and support various clinical operations and compliance initiatives,” said Paul J. Silver, managing director and practice leader, Huron Life Sciences. “We developed the trialRx service to further support the strategic, clinical and regulatory compliance needs of our clients in a world where data is everywhere – and where being able to use it is critical.”

Risk Exposure and Data Quality

The trialRx service equips companies to understand their overall risk exposure on for each of their clinical trials. Huron’s clients have experienced a reduction in overall noncompliance and realized additional value by using the service to enhance data quality, create business insights and identify operations improvement opportunities. Specifically, clients have used the trialRx service to identify and remediate data quality issues including errant clinical trial sponsor listings, duplicate secondary IDs, lack of universal trial numbers and identification of non-harmonized study conditions and interventions.

“Our trialRx service fills a distinct need in the marketplace by closing the loop between what is posted by clinical trial sponsors – either manually or using trial data disclosure solutions – and what regulators require,” said BJ D’Avella, director, Huron Life Sciences. “It provides sponsors an efficient, cost-effective way to understand their evolving clinical trial portfolios and can be customized to meet our clients’ unique business and compliance needs.”

Huron’s trialRx service is compatible with existing software solutions that automate aspects of the posting of trials to and can help ensure that those postings are complete, accurate, and timely.

For more information on Huron’s trialRx service or to request a demo, visit:

About Huron Life Sciences

Huron Life Sciences serves pharmaceutical, medical device and biotechnology companies, healthcare providers, academic medical centers and the law firms and investment firms that support these organizations to achieve financial, operational, and strategic objectives. Learn more at or follow us on Twitter: @Huron.

About Huron Consulting Group

Huron Consulting Group helps clients in diverse industries improve performance, transform the enterprise, reduce costs, leverage technology, process and review large amounts of complex data, address regulatory changes, recover from distress and stimulate growth. Our professionals employ their expertise in finance, operations, strategy and technology to provide our clients with specialized analyses and customized advice and solutions that are tailored to address each client's particular challenges and opportunities to deliver sustainable and measurable results. The Company provides consulting services to a wide variety of both financially sound and distressed organizations, including healthcare organizations, leading academic institutions, Fortune 500 companies, governmental entities and law firms. Huron has worked with more than 425 health systems, hospitals, and academic medical centers; more than 400 corporate general counsel; and more than 350 universities and research institutions. Learn more at

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.24 0.00%
FB $117.81 0.00%
GOOG $701.43 0.00%
TSLA $211.53 0.00%
YHOO $36.94 0.00%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs